Sanai Health Industry Group Company Limited (Sanai Health) announced that all seven ordinary resolutions proposed at the 26 June 2026 Annual General Meeting (AGM) were approved, each receiving 99.20% of the votes cast.

A total of 45.38 million shares, representing 29.68% of Sanai Health’s 152.90 million issued shares, were voted in person or by proxy. Boardroom Share Registrars (HK) Limited acted as scrutineer.

Key outcomes:

1. Financial statements for the year ended 31 December 2025, along with the directors’ and auditors’ reports, were adopted with 45.02 million votes in favour versus 0.36 million votes against.

2. Board composition was confirmed: • Executive director Mr. She Hao was re-elected. • Independent non-executive director Mr. Khor Khie Liem Alex was re-elected. • Executive director Mr. Xie Haijing was re-elected. Directors’ remuneration will continue to be set by the Board.

3. Forvis Mazars CPA Limited was appointed as the Company’s auditors, with authority granted to the Board to determine their remuneration.

4. Shareholders renewed the general mandate authorising the Board to: • Issue new shares or sell/transfer treasury shares up to 20% of the Company’s issued share capital. • Repurchase shares up to 10% of issued share capital. • Extend the issuance mandate by the number of shares repurchased under the repurchase mandate.

No shareholders were required to abstain from voting, and no votes were cast against any resolution in significant proportion. The Board attendance included executive directors Mr. Yuan Chaoyang and Mr. Xie Haijing, along with all three independent non-executive directors.

The AGM results reaffirm shareholder endorsement of Sanai Health’s governance framework and capital management flexibility for the year ahead.